Susan Lee Lindquist, ForMemRS was an American professor of biology at MIT specializing in molecular biology, particularly the protein folding problem within a family of molecules known as heat-shock proteins, and prions. Lindquist was a member and former director of the Whitehead Institute and was awarded the National Medal of Science in 2010.
Robert Allan Weinberg is a biologist, Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology (MIT), director of the Ludwig Center of the MIT, and American Cancer Society Research Professor. His research is in the area of oncogenes and the genetic basis of human cancer.
Ruth Arnon is an Israeli biochemist and codeveloper of the multiple sclerosis drug Copaxone. She is currently the Paul Ehrlich Professor of Immunology at the Weizmann Institute of Science, where she is researching anti-cancer and influenza vaccinations.
Eva Nogales is a Spanish-American biophysicist at the Lawrence Berkeley National Laboratory and a professor at the University of California, Berkeley, where she served as head of the Division of Biochemistry, Biophysics and Structural Biology of the Department of Molecular and Cell Biology (2015–2020). She is a Howard Hughes Medical Institute investigator.
Elaine V. Fuchs is an American cell biologist famous for her work on the biology and molecular mechanisms of mammalian skin and skin diseases, who helped lead the modernization of dermatology. Fuchs pioneered reverse genetics approaches, which assess protein function first and then assess its role in development and disease. In particular, Fuchs researches skin stem cells and their production of hair and skin. She is an investigator at the Howard Hughes Medical Institute and the Rebecca C. Lancefield Professor of Mammalian Cell Biology and Development at The Rockefeller University.
The International Human Frontier Science Program Organization (HFSPO) is a non-profit organization, based in Strasbourg, France, that funds basic research in life sciences. The organization implements the Human Frontier Science Program (HFSP) and is supported by 14 countries and the European Commission. Shigekazu Nagata is the HFSPO President and Chair of the Board of Trustees since 2018.
Ming-Ming Zhou is an American scientist whose specification is structural and chemical biology, NMR spectroscopy, and drug design. He is the Dr. Harold and Golden Lamport Professor and Chairman of the Department of Pharmacological Sciences. He is also the co-director of the Drug Discovery Institute at the Icahn School of Medicine at Mount Sinai and Mount Sinai Health System in New York City, as well as Professor of Sciences. Zhou is an elected fellow of the American Association for the Advancement of Science.
Ruth Nussinov is an Israeli-American biologist born in Rehovot who works as a Professor in the Department of Human Genetics, School of Medicine at Tel Aviv University and is the Senior Principal Scientist and Principal Investigator at the National Cancer Institute, National Institutes of Health. Nussinov is also the Editor in Chief of the Current Opinion in Structural Biology and formerly of the journal PLOS Computational Biology.
Anne Jacqueline Ridley is professor of Cell Biology and Head of School for Cellular and Molecular Medicine at the University of Bristol. She was previously a professor at King's College London.
Caroline Dive is a British cancer research scientist. Dive is Professor of Cancer Pharmacology at the University of Manchester, Deputy Director of the Cancer Research UK (CRUK) Manchester Institute, Director of the CRUK Manchester Institute Cancer Biomarker Centre and co-director of the CRUK Lung Cancer Centre of Excellence. She is the current President of The European Association for Cancer Research (EACR).
(Robert) Charles Swanton is British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute, Royal Society Napier Professor in Cancer and thoracic medical oncologist at University College London and University College London Hospitals, co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.
Galit Lahav is an Israeli-American systems biologist and Professor of Systems Biology at Harvard Medical School. In 2018 she became Chair of the Department of Systems Biology at Harvard Medical School. She is known for discovering the pulsatile behavior of the tumor suppressor protein p53 and uncovering its significance for cell fate, and for her contributions to the culture of mentoring in science. She lives in Boston, Massachusetts.
Vivian Li is a Hong Kong-born cell and developmental biologist working in cancer research at London's Francis Crick Institute. She has been researching how stem cells in the human bowel are programmed to ensure a healthy organ and what goes wrong when cancer develops. She is known for her work on the Wnt signalling pathway, discovering a new way that a molecule called Wnt is activated in bowel cancer. She won a Future Leaders in Cancer Research Prize in part for this discovery.
Rebecca Julia Shipley is a British mathematician and professor of healthcare engineering at University College London (UCL). She is director of the UCL Institute of Healthcare Engineering, co-director of the UCL Centre for Nerve Engineering and Vice Dean (Health) for the UCL Faculty of Engineering Sciences. She is also co-director of the UCL CHIMERA Research Hub with Prof Christina Pagel and a Fellow of the Institution of Engineering and Technology.
Elizabeth Mary Claire Fisher is a British geneticist and Professor at University College London. Her research investigates the degeneration of motor neurons during amyotrophic lateral sclerosis and Alzheimer's disease triggered by Down syndrome.
Jason Sheltzer is a cancer biologist at the Yale University School of Medicine.
Yardena Samuels or Samuels-Lev is an Israeli molecular biologist who is the Director of the Ekard Institute for Cancer Diagnosis Research at the Weizmann Institute of Science. Her research considers the genetic mutations of melanoma.
Martin Hetzer is an Austrian-born molecular biologist and President of the Institute of Science and Technology Austria (ISTA). He is holder of the Jesse and Caryl Philips Foundation Chair in Molecular Cell Biology. His research focuses on fundamental aspects of organismal aging with a special focus on the heart and central nervous system. His laboratory has also made important contributions in the area of cancer research and cell differentiation.
Nissim Benvenisty is Professor of Genetics, the Herbert Cohn Chair in Cancer Research and the Director of “The Azrieli Center for Stem Cells and Genetic Research” at the Alexander Silberman Institute of Life Sciences, Hebrew University.
Sima Lev is an Israeli biologist and the Joyce and Ben B. Eisenberg Professorial Chair of Molecular Cell Biology at the Weizmann Institute of Science. She looks to uncover the mechanisms that drive the development of triple-negative breast cancer, and to identify new therapeutic strategies.
